Search results
Weekly-once insulin jab may soon come to India
The Economic Times· 4 days agoIn what could be a respite for people who need insulin jabs every day, a new weekly insulin dosage by Danish drug maker Novo Nordisk has got closer to...
India Approves The Weight Loss & Diabetes Drugs: Everything You Need To Know
NDTV· 4 days agoEli Lilly and Co., the pharmaceutical company, has secured the first approvals for the import and...
Obesity disease management needs to be revolutionised
Pharmaceutical Technology· 6 days agoObesity has only recently been recognised as a disease as opposed to a behavioural/lifestyle issue....
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro - ET HealthWorld | Pharma
The Economic Times· 6 days agoLilly's Mounjaro, chemically known as tirzepatide, and Zepbound and Danish rival Novo Nordisk's...
Govt panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Business Standard India· 6 days agoLilly's Mounjaro, chemically known as tirzepatide, and Zepbound and Danish rival Novo Nordisk's...
Who is Rishi Shah? Indian-American billionaire gets 7.5-year prison for defrauding investors...
Hindustan Times· 5 days agoIndian-American Rishi Shah, 38, the co-founder of Outcome Health, which provided ads on TVs in...
Matr Foods aims to scale alt-meat volumes with new factory plans
Just Food· 3 days agoLast week, the company secured funding from Novo Holdings, the investment arm of the Danish...
Can weight-loss drugs Ozempic and Wegovy cause blindness?
Firstpost· 3 days agoThe world has long been concerned about obesity. It has long been known for its connections to...
FTC investigates Teva over contested product patents
Pharmaceutical Technology· 4 days agoAs per the report, Teva has until 24 July to comply with the FTC’s order. The FTC first waded into the dispute in April when the commission sent warning...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 6 days agoLilly's Mounjaro, chemically known as tirzepatide, and Zepbound and Danish rival Novo Nordisk's...